IL-6 mutein and DNA encoding thereto
    1.
    发明授权
    IL-6 mutein and DNA encoding thereto 有权
    IL-6突变蛋白和编码它的DNA

    公开(公告)号:US06280975B1

    公开(公告)日:2001-08-28

    申请号:US09155941

    申请日:1999-04-06

    IPC分类号: C12N510

    CPC分类号: C07K14/5412 A61K38/00

    摘要: The present invention relates to a new IL-6 mutein, a DNA sequence coding for it, its use in therapy as well as a pharmaceutical composition comprising it. It is a potent IL-6 antagonist and can be advantageously used as a medicament in the treatment of diseases in which IL-6 has a pathogenetic action, such as, for example, plasmocytoma/myeloma, osteoporosis and neoplastic and auotoimmune diseases.

    摘要翻译: 本发明涉及新的IL-6突变蛋白,编码它的DNA序列,其在治疗中的应用以及包含它的药物组合物。 它是有效的IL-6拮抗剂,并且可以有利地用作治疗其中IL-6具有致病作用的疾病的药物,例如浆细胞瘤/骨髓瘤,骨质疏松症和肿瘤性和自身免疫性疾病。